No Detail Found!

A New Player in the Game; Exploring the Prospective Role of Serotonin Dysfunction in Diabetic-Induced Depression: Preclinical and Clinical Evidence

Author(s)
Eslam Kamal Fahmy Department of Physiology, College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Safya Ebraheem Esmaeel Department of Physiology, College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Raghad Saad Alenezi College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Basmah Dhiyab Alanazi College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Watin Hamdan Alenezi College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Dana Awad Alhazmi College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Baraah Abu Alsel Medical Sciences and Preparatory Year Department, North Private College of Nursing, 73244, Arar, Saudi Arabia
Abstract
Diabetes mellitus and major depressive disorder frequently coexist, creating a bidirectional relationship that worsens clinical outcomes, glycemic control and quality of life. Emerging evidence suggests that serotonergic dysfunction may represent a key mechanistic link between metabolic dysregulation and mood disorders. This review explores the prospective role of serotonin (5-hydroxytryptamine, 5-HT) disturbances in the pathophysiology of diabetic-induced depression by integrating findings from both preclinical and clinical studies. Preclinical investigations using streptozotocin-induced, dietinduced and genetic models of diabetes consistently demonstrate alterations in central and peripheral serotonin levels, impaired tryptophan metabolism, changes in tryptophan hydroxylase and monoamine oxidase activity and regio-specific reductions of 5-HT within mood-regulating brain structures such as the hippocampus, cortex and hypothalamus. These neurochemical changes are frequently accompanied by depressive-like behaviors in validated behavioral paradigms. Additionally, diabetes is associated with modifications in serotonin transporter (SERT) function and altered expression of several serotonin receptor subtypes, including 5-HT1A and 5-HT2 receptors, suggesting disruption of serotonergic signaling pathways involved in emotional regulation and neuroplasticity. Clinical evidence further supports this relationship, indicati ng that diabetic patients often exhibit serotonergic abnormalities, inflammatory activation, insulin resistance-related neurotransmitter changes and gutbrain axis alterations that may contribute to depressive symptomatology. Therapeutically, selective serotonin reuptake inhibitors (SSRIs) and other serotonin-modulating strategies show potential benefits not only in alleviating depressive symptoms but also in influencing metabolic parameters. Collectively, the available evidence positions serotonin dysfunction as a promising mechanistic bridge between diabetes and depression. Understanding these interactions may open new avenues for integrated therapeutic strategies targeting both metabolic and neuropsychiatric components of diabetic-induced depression.
Publication Details
Page(s) 79-83
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 5, Year: 2026

Request the full text from PASTIC

Keywords
T2DM, Major Depressive Disorder, SSRIs, Serotonin, Diabetic-Induced Depression
References
Prabhakar V.,Diabetes-Associated Depression . .The Serotonergic System as a Novel Multifunctional Target. Indian Journal of Pharmacology, 47(2015) : 150305-7613.
Palazzo E. . .. Affective and Cognitive Impairments in Rodent Models of Diabetes.” Current Neuropharmacology, 22(2024) : 1327-1343.
Homberg J.R. .2009 .Serotonin Transporter Deficiency Increases Abdominal Fat in Female, but Not Male Rats. ” Obesity, 139(2010) : 137-145.
Khawagi ,Pathway Mechanistic . .Depression and Type 2 Diabetes: A Causal Relationship. Obesity & Metabolism, 26(2024) : 3031-3044.
Derkach K.V. .2015 .The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes. International Journal of Endocrinology, : .
Kuo H.Y. . .Antidepressants and Risk of Type 2 Diabetes Mellitus: A Population-Based Nested Case-Control Study. ” Journal of Clinical Psychopharmacology, 40(2020) : 0000000000001-228.
Anthony D.C. .2024 .Plasma Metabolome Changes and ADHD-like Behavior in Mice Fed a Western Diet. ” Biomolecules, 14(8) : .
Malik A. . .Impact of Serotonin Transporter Gene Polymorphism on Gut Motility in Patients with Type 2 Diabetes Mellitus. ” Journal of Neurogastroenterology and Motility, 27(2021) : 240-247.
Alruwaili N.S. .2023 .Antidepressants and Type 2 Diabetes: Highways to Knowns and Unknowns. Diabetology & Metabolic Syndrome, 15(1) : .
Yoo Y.M.,Joo S.S. .2024 .Serotonin Influences Insulin Secretion in Rat Insulinoma INS-1E Cells. International Journal of Molecular Sciences, 25(13) : .
Pomytkin I.A. .2014 .Function: A Reciprocal Risk Factor for Depression and Insulin Resistance?” Behavioural Brain Research. , 04 : 111-117.
Rowland N.E.,Bellush L.L. . .. Diabetes Mellitus: Stress, Neurochemistry and Behavior.” Neuroscience and Biobehavioral Reviews, 7634(89) : 80054-5.
Calzadilla N. .2024 .Serotonin Transporter Deficiency Induces Metabolic Alterations in the Ileal Mucosa. International Journal of Molecular Sciences, 25(8) : .
Siafis S.,G. Papazisis. S. .2018 .Detecting a Potential Safety Signal of Antidepressants and Type 2 Diabetes: A Pharmacovigilance-Pharmacodynamic Study. British Journal of Clinical Pharmacology, 84(10) : 2405-2414.
Kolling L.J.,Dysfunction Metabolic .2024 .Interaction of Serotonin/GLP-1 Circuitry in a Dual Preclinical Model for Psychiatric Disorders. Psychiatry Research, 115951 : .
Fanelli G. .2025 .. The Interface of Depression and Diabetes: Treatment Considerations.” Translational Psychiatry, 15(1) : .
Veniaminova E. .2020 .Metabolic, Molecular and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?” Frontiers in Neuroscience. , 00024 : .
0

Citations

0

Downloads

15

Views